Prophylactic antimicrobial agents and the importance of fitness

被引:25
作者
Baden, LR
机构
关键词
D O I
10.1056/NEJMe058133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1052 / 1054
页数:3
相关论文
共 15 条
[1]   Quinolones and false-positive urine screening for opiates by immunoassay technology [J].
Baden, LR ;
Horowitz, G ;
Jacoby, H ;
Eliopoulos, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24) :3115-3119
[2]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[3]   Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia [J].
Bucaneve, G ;
Micozzi, A ;
Menichetti, F ;
Martino, P ;
Dionisi, MS ;
Martinelli, G ;
Allione, B ;
D'Antonio, D ;
Buelli, M ;
Nosari, AM ;
Cilloni, D ;
Zuffa, E ;
Cantaffa, R ;
Specchia, G ;
Amadori, S ;
Fabbiano, F ;
Deliliers, GL ;
Lauria, F ;
Foà, R ;
Del Favero, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :977-987
[4]   EMERGENCE OF QUINOLONE-RESISTANT ESCHERICHIA-COLI BACTEREMIA IN NEUTROPENIC PATIENTS WITH CANCER WHO HAVE RECEIVED PROPHYLACTIC NORFLOXACIN [J].
CARRATALA, J ;
FERNANDEZSEVILLA, A ;
TUBAU, F ;
CALLIS, M ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :557-560
[5]   Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas [J].
Cullen, M ;
Steven, N ;
Billingham, L ;
Gaunt, C ;
Hastings, M ;
Simmonds, P ;
Stuart, N ;
Rea, D ;
Bower, M ;
Fernando, I ;
Huddart, R ;
Gollins, S ;
Stanley, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :988-998
[6]   A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy [J].
Freifeld, A ;
Marchigiani, D ;
Walsh, T ;
Chanock, S ;
Lewis, L ;
Hiemenz, J ;
Hiemenz, S ;
Hicks, JE ;
Gill, V ;
Steinberg, SM ;
Pizzo, PP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :305-311
[7]   Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients [J].
Gafter-Gvili, A ;
Fraser, A ;
Paul, M ;
Leibovici, L .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :979-995
[8]   Emerging mechanisms of fluoroquinolone resistance [J].
Hooper, DC .
EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :337-341
[9]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[10]   EMERGENCE OF FLUOROQUINOLONE-RESISTANT ESCHERICHIA-COLI AT A CANCER CENTER [J].
KERN, WV ;
ANDRIOF, E ;
OETHINGER, M ;
KERN, P ;
HACKER, J ;
MARRE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :681-687